Research Progress in the Adjuvant Treatment of non-small Cell Lung Cancer with Chinese Medicine Injections
DOI:
https://doi.org/10.53469/jcmp.2024.06(08).26Keywords:
Traditional Chinese medicine injection, Non-small cell lung cancer, Combination of traditional Chinese medicine and western medicine, reviewAbstract
Non-small cell lung cancer (NSCLC) is a common type of lung cancer. Patients with advanced NSCLC often lose the chance of surgery. Integrated traditional Chinese and western medicine therapy, especially traditional Chinese medicine injection, has shown its advantages in the treatment of non-small cell lung cancer. It plays an anti-cancer role by inhibiting cell proliferation, promoting apoptosis, inhibiting tumor invasion and metastasis, and improving anti-tumor drug resistance. It has shown advantages in reducing adverse reactions, improving efficacy and quality of life of patients.
References
Oncology Society of Chinese Medical Association, Chinese Medical Association Publishing House. Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition) [J]. Zhonghua Zhongliu Zazhi, 2023, 45(7): 539-574.
Passaro A, Leighl N, Blackhall F, et al. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer [J]. Ann Oncol, 2022, 33(5): 466-487.
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
Jin M H, Tang J, Qin J L, et al. Epidemiological analysis of lung cancer from 2002 to 2020 [J]. Chinese Journal of Medicine, 2019, 34(6):34-38.
Pi Weiping. Research on Chinese medicine evidence and identification and typing of non-small cell lung cancer [D]. Beijing: Beijing University of Chinese Medicine, 2017.
WANG Junhui, XIAO Meng, MA Gongxian, et al. Research progress in traditional Chinese medicine treatment of non-small cell lung cancer, [J]Shaanxi Journal of Traditional Chinese Medicine, , 2021, 34(6):34-38.
FU Xiaoqing, Dai Zhoujuan, XIA Tao-tao, et al. Correlation analysis between pathological staging of lung cancer and Chinese medicine evidence[J]. Zhejiang Journal of Traditional Chinese Medicine, 2024, 59(07):603-604.
Wang YL, Wang Q, Li H, et al. Sestrin2 mediates FOXM1 expression to block the EMT process in non-small cell lung cancer through the AMPK/YAP pathway[J]. Neoplasma, 2023, 70(1):46-57.
XIAO Zhenzhen, ZHU Yanjuan, YU Yaya, et al. Effect of Reduning Injection, Shenfu Injection Combined with Gefitinib on Proliferation, Stemness Characteristics and Metabolism of Non-small Cell Lung Cancer Cells[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2023, 29(18):45-53.
Wei Xueqin. Inhibitory effect of Aidi injection combined with amlotinib hydrochloride on neovascularisation in non-small cell lung cancer based on VEGF/MAPK signaling pathway[D]. Tianjin: Tianjin University of Traditional Chinese Medicine, 2023.
ZHUO X F, JI Y H. Inhibition of matrine against proliferation, invasion and angiogenesis of lung cancer tumor A549 cell and its mechanism[J]. Drugs & Clinic, 2017, 32(5): 767-771.
YANG J, HE D, PENG Y, et al. Matrine suppresses the migration and invasion of NSCLC cells by inhibiting PAX2-induced epithelial-mesenchymal transition[J]. OncoTargets and Therapy, 2017, 10: 5209-5217.
FANG Chuanci, QIAN Yayun. Effect of Sodium Cantharidinate Injection Targeting PI3K/AKT/mTOR Signaling Pathway on the Migration Ability of Human Lung Adenocarcinoma Cell A549[J]. Acta Chinese Medicine, 2021, 36(9):1954-1958.
Liu Qiaozhen, Fan Renyan, Zhou Linping. Study on the therapeutic effect of Aidi injection combined with TP Regimen on non-small cell lung cancer [J]. Contemporary Medicine, 2020, 26(07):139-141.
ZHOU Juan, FU Ping, HAN Hui, et al. Effect of Kanglaite Injection adjuvant chemotherapy on lung function and cancer pain in patients with advanced non-small cell lung carcinoma[J]. Journal of Hubei University of Chinese Medicine, 2021, 23(4):34-36.
Tang Zhongming, Huang Naixin, Guo Hengzhao. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine[J]. Practical Chinese and Western medicine combined clinic, 2019, 19(01):148-149.
Guo Chunhui, Dong Jianchun, Yin Yanhai, et al. Analysis of the efficacy and safety of Aidi injection combined with chemotherapy in the treatment of elderly patients with non-small cell lung cancer[J]. Journal of China Prescription Drug, 2020, 18(10):119-120.
Yi Fei, Liu Lei, Zhang Jun. Sensitization effect and mechanism of Brucea Javanica oil emulsion on cisplatin chemotherapy in lung cancer A549 cells[J]. Shandong Medical Journal, 2024, 64(5):40-43.
PAN Pengyu, ZHOU Huan, XU Ming, et al. Study on Kang’ai injection regulating Beclin 1-dependent autophagy-apoptosis interaction and improving cisplatin resistance in A549/DDP cells[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2022, 36(4):41-51.
ZHOU Huan, SUN Ye, LIU Chunying, et al. Study on Improvement of Cisplatin Resistance of A549/DDP Cells by Kang’ai Injection Based on FOXO3a Regulated Glycolysis Pathway[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2022, 24(5):13-18.
WU Qihang, ZHANG Xiaoli, SONG Yanping. The Current Situation and Outlet of Traditional Chinese Medicine Injection[J]. CHINESE AND FOREIGN MEDICAL RESEARCH, 2019, 17(36):185-188.
Chen Minghui, Liu Tao, Su Yuxia, et al. Efficacy and safety of different dosages of Cinbufosin injection combined with chemotherapy in treatment of advanced lung cancer [J]. Chinese Remedies & Clinics, 2019, 20(19):3241-3243.
Wu Weilong. Efficacy of huachunin injection combined with vincristine + cisplatin chemotherapy regimen for advanced non-small cell lung cancer[J]. Chronic Pathematology Journal, 2022, 23(11):1718-1720.
MI Suicai, WU Lingyan, CHEN Zhiming, et al. Objective to Compare The Clinical Efficacy of Arotinib Combined With Cinobufacin or Cisplatin in The Treatment of Non-small Cell Lung Cancer With Malignant Pleural Effusion[J]. Medical Innovation of China, 2021, 18(4):81-84.
FAN Xinyue, YANG Luming, FU Jiali, et al. Research Progress in Chemical Components and Pharmacological Action of Brucea [J]. Chinese Pharmaceutical Journal, 2022, 57(14):1137-1145.
DU Chongwei, LIU Xi, ZHANG Jiali. Effects of Sijunzi Tang combined with Crowberry Oil Milk Injection on immune function, tumour marker levels and lung function in patients with non-small cell lung cancer[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2023, 32(9):1277-1281.
HE Hua, ZHOU Yujie, LI Tian. Effect of bruceolic oil emulsion adjuvant PC regimen chemotherapy on immune function and inflammatory factors in NSCLC[J]. Chinese Journal of Lung Diseases (Electronic Edition), 2023, 16(5):697-699.
LI Bin, BAI Huihui, ZHANG Yi, et al. Observation of the clinical effect of brucea javanica oil emulsion injection combined with gefitinib in treating non-small cell lung cancer and its effect on patients’serum indicators[J]. Oncology Progress, 2021, 19(10):1011-1014.
WANG Lei, ZHANG Meng, YU Lijie, et al. Research progress of compound Kushen injection in the adjuvant treatment of non-small cell lung cancer[J]. World Clinical Drug, 2023, 44(02):117-121.
Li K, Xiao K, Zhu S, et al. Chinese herbal medicine for primary liver cancer therapy: perspectives and challenges[J]. Front Pharmacol, 2022, 13: 889799.
Ye Z, Yao X, Chen Z, et al. Exploring the nucleotide molecular mechanism of compound Kushen injection for lung adenocarcinoma based on network pharmacology and molecular docking[J]. Front Oncol, 2022, 12: 1013052.
Chen Jiayi, Song Jian, He Jiajian, et al. Research progress of Chinese medicine injection in adjuvant treatment of non-small cell lung cancer[J]. World Clinical Drug, 2024, (6): 673-677.
Zuo Nian, Liang Liang. Effect of compound bitter ginseng injection combined with AP regimen on immune function and serum IL-6, IL-10 and TNF-α levels in patients with non-small cell lung cancer[J]. The Journal of Medical Theory and Practice, 2021, 34(24):4290 - 4291.
YING Weiping, ZHONG Guomei. Clinical Study on Compound Kushen Injection Combined with Osimertinib Mesylate Tablets for Epidermal Growth Factor Receptor Gene Mutation in Advanced NonSmall Cell Lung Cancer[J]. New Chinese Medicine, 2024, 56(2):147-150.
Kuang Yunfeng, Chen Gaofeng, Huang Zhongdeng, et al.Clinical Observation of Sanhuang Wuxue Acupuncture Method Combined with Shen Qi Fuzheng Injection for the Treatment of Fatigue in Lung Cancer Patients with Qi and Blood Deficiency Syndrome[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2022, 39(12):2847-2854.
Chen Weixia, Niu Yao-fei, KANG Yan, et al. Research status of antitumor Chinese patent medicine injection [J]. Chinese Journal of Gerontology, 2021, 41(23):5439-5444.
LIU Jingjing, YI Liangjie. Clinical Efficacy of Shenqi Fuzheng Injection Adjuvant Carrelizumab Combined with Chemotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2024, 32(2):29-33.
Zhang Jingxian. Clinical study on the treatment of driver gene-negative non-small cell lung cancer with shenqi fu zheng injection combined with endu and PD-1 inhibitor[D]. Tianjin: Tianjin University of Traditional Chinese Medicine, 2023.
Zhang Hongyan, Bi Hongyu. Research Progress of Kangai Injection [J]. Drug Evaluation, 2022, 12 (3): 189-192.
Zhu Shicong, Wang Heling, Xu Ya, et al. Clinical Study of Kangai Injection Combined with PP Regimenin the Treatment of Advanced Lung Adenocarcinoma Patients with Spleen-Lung Qi Deficiency[J]. Herald of Medicine, 2020, 39(4):572-576.
YAO Yilin, LI Hegen, CHEN Zhiwei, et al. Clinical study on Jianpi Wenshen Ruanjian Jiedu formula, Kang’ai injection and low-dose chemotherapy in the treatment of advanced non-small cell lung cancer of spleen kidney deficiency type in the elderly[J]. Shanghai Journal of Traditional Chinese Medicine, 2020, 54(3):67-71.
Wu Y Q. Clinical effect of Kangai injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer [J]. Chinese Journal of Clinical Rational Drug Use, 2021, 14(18):76-78.
Yan Dixue. Clinical effect of Shashen Maodong Decoction combined with etoposide and cisplatin in the treatment of patients with small cell lung cancer [J]. Chinese Journal of Clinical Rational Drug Use, 2012, 15(20):71-75.
Song Xuewei, Zhang Kuisong. Effect of Shenmai Injection Combined with chemotherapy on middle and Advanced Lung Cancer of Qi-Yin Deficiency Type [J]. World Journal of Complex Medicine, 2019, 9(11):104-107.
Li Hongyu. Efficacy of Aidi injection combined with gefitinib in patients with non-small cell lung cancer[J]. Henan Medical Research, 2021, 30(10):1878-1880.
LIU Guiju, LI Lu, ZHAO Qingqing, et al. Clinical efficacy of Aidi Injection combined with conventional chemotherapy in patients with lung cancer brain metastasis[J]. Chinese Remedies & Clinics, 2024, 24(2):102-106.
ZHU Guanghui, ZHENG Qi, GAO Ruike, et al. Kanglaite injection regulates cholesterol metabolism to inhibit the malignant biological behavior of lung adenocarcinoma A549 cells[J]. Chinese Journal of Cancer Biotherapy, 2023, 30(11):973-980.
WANG Xiaozhen, YANG Lixin, LI Danqing, et al. Clinical effect of intensity modulated radiotherapy combined with Kanglaite injection in the treatment of elderly patients with non-small cell lung cancer and its effect on immune function[J]. China Medicine, 2024, 19(2):198-201.
ZHANG Hengli, ZHANG Zhengwei. Clinical observation of Conrad combined with thoracic hypotonic retention perfusion paclitaxel plus lopressor in the treatment of malignant pleural effusion complicated by non-small cell lung cancer[J]. Journal of Clinical Internal Medicine, 2022, 39(7):472-474.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yixuan Cao, Hailong Si
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
